Skip to main content
Porto

Main navigation

  • Home
  • PMMNG Meetings
    • PMMNG Monthly Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma 5K
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

bispecific and trispecific antibodies

Myeloma Crowd logoWhat: Webcast audio (1:23:20)
When: Friday January 22, 2021 4:00 PM ET
Where: Web

Tags
event
webcast
archived
clinical trials
ash
combination therapies
newly diagnosed myeloma
expected fda approvals
car-t
bispecific and trispecific antibodies
antibody drug conjugates
targeted inhibitors
mgus
smoldering myeloma
Dr. Robert Orlowski
  • Read more about Myeloma Crowd: Multiple Myeloma Care in 2021

Myeloma Crowd logoWhat: Webcast videos
When: Saturday April 10, 2021
Where: Web
Access webcast videos

Tags
event
webcast
archived
clinical trials
car-t
abecma
ide-cel
cilta-cel
blenrep
bispecific and trispecific antibodies
bispecific t-cell engager
bite
antibody drug conjugates
targeted inhibitors
bcma
gprc5d
fcrh5
Dr. Alexander Lesokhin
Dr. Krina Patel
  • Read more about Myeloma Crowd: Myeloma Crowd Roundtable - BCMA and Other Targets

Myeloma Crowd logoWhat: Webcast recording (50:17)
When: Monday February 7, 2022 3:00 PM ET
Where: Web

Tags
event
webcast
archived
myeloma crowd
research
treatment
ash
clinical trials
car-t therapy
bispecific and trispecific antibodies
antibody drug conjugates
targeted inhibitors
mgus
smoldering myeloma
Dr. Robert Orlowski
  • Read more about Myeloma Crowd: Looking Forward in 2022 for Multiple Myeloma with Robert Orlowski
Subscribe to bispecific and trispecific antibodies